{"disease":{"id":"gastroesophageal-reflux-disease-gerd","name":"gastroesophageal reflux disease gerd"},"drugs":{"marketed":[{"drug_id":"palazestrant","indication_name":"Treatment of gastroesophageal reflux disease (GERD) in patients who have not responded adequately to proton pump inhibitor (PPI) therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Palazestrant","generic_name":"palazestrant","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"estrogen receptor","drug_class":"estrogen receptor antagonist and degrader","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"rabeprazole-40-mg","indication_name":"Gastroesophageal Reflux Disease (GERD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rabeprazole 40 mg","generic_name":"rabeprazole-40-mg","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"H+/K+ ATPase","drug_class":"Proton Pump Inhibitor","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"rabeprazole-40-mg","indication_name":"Gastroesophageal Reflux Disease (GERD) in Pediatric Patients 1 to 11 Years Old","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rabeprazole 40 mg","generic_name":"rabeprazole-40-mg","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"H+/K+ ATPase","drug_class":"Proton Pump Inhibitor","quality_score":45,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06974903","title":"Retrospective Observational Study on GERD Management in General Hospitals in Korea","phase":"","overall_status":"COMPLETED","enrollment_count":13750,"lead_sponsor_name":"Chong Kun Dang Pharmaceutical","has_results":false},{"nct_id":"NCT05870163","title":"Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment","phase":"","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Implantica CE Reflux Ltd.","has_results":false},{"nct_id":"NCT03561883","title":"Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":609,"lead_sponsor_name":"Ironwood Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03561090","title":"A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":495,"lead_sponsor_name":"Ironwood Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT00838526","title":"Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Eisai Inc.","has_results":true},{"nct_id":"NCT01940185","title":"A Post-Approval Study of the LINX® Reflux Management System","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Torax Medical Incorporated","has_results":false},{"nct_id":"NCT07344935","title":"Evaluation of the Effectiveness of the Ezisurg Stapling (Ezi Endo Lite) During Laparoscopic Nissen Sleeve Gastrectomy","phase":"NA","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Ezisurg Medical Co. Ltd.","has_results":false},{"nct_id":"NCT06862037","title":"Development of Machine Learning Models to Predict Postoperative GERD Symptom Resolution After Laparoscopic Nissen Fundoplication","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":112,"lead_sponsor_name":"Korea University Anam Hospital","has_results":false},{"nct_id":"NCT04130659","title":"Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone","phase":"NA","overall_status":"UNKNOWN","enrollment_count":110,"lead_sponsor_name":"Nekkar Lab Srl","has_results":false},{"nct_id":"NCT02616302","title":"A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT01647958","title":"The EndoGastric Solutions TEMPO Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"EndoGastric Solutions","has_results":true},{"nct_id":"NCT07174882","title":"Evaluation of the Clinical Course of NERD and Assessment of the Esophageal Mucosa Resistance","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT04660019","title":"Combined Scalp and Ear Acupuncture in Patients With Proton Pump Inhibitor- Dependent Gastroesophageal Reflux Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Taipei Medical University WanFang Hospital","has_results":false},{"nct_id":"NCT06916130","title":"A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Addpharma Inc.","has_results":false},{"nct_id":"NCT07176221","title":"Endoscopic Cardial Constriction Ligation (ECCL) for Refractory GERD Using a Disposable Endoscope","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":46,"lead_sponsor_name":"Ying Zhu","has_results":false},{"nct_id":"NCT03367195","title":"Efficacy and Safety of DLBS2411 in the Management of GERD","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":32,"lead_sponsor_name":"Dexa Medica Group","has_results":false},{"nct_id":"NCT05579587","title":"Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}